ARTICLE | Company News
Titan partners Spheramine with Schering
February 2, 2000 8:00 AM UTC
Schering received exclusive worldwide development and marketing rights to TTP's Spheramine retinal pigmented epithelial cell therapy, which produces dopamine, to treat Parkinson's disease. TTP will re...